Emily E. Brown

1.1k citations

20 papers · 887 indexed · h-index 13

Impact in

Ophthalmology top 2%
- Retinal Diseases and Treatments
Molecular Biology
- Retinal Development and Disorders
- Glycosylation and Glycoproteins Research
- RNA Interference and Gene Delivery
- Cell death mechanisms and regulation

Papers in ⓘ

Ophthalmology 7
- Retinal Diseases and Treatments 6
Physiology 3
- Calcium signaling and nucleotide metabolism 3

Co-authors: John D. Ash (7 shared papers)Alfred S. Lewin (6 shared papers)Cristhian J. Ildefonso (3 shared papers)Linda Maggiora (1 shared paper)John G. Hoogerheide (1 shared paper)Åke P. Elhammer (1 shared paper)Ferenc J. Kézdy (1 shared paper)Roger A. Poorman (1 shared paper)
Journals: Advances in experimental medicine and biology (3 papers)Investigative Ophthalmology & Visual Science (3 papers)Human Molecular Genetics (2 papers)Redox Biology (2 papers)Molecular Therapy — Methods & Clinical Development (2 papers)
Partner nations: United States China Germany

In The Last Decade

Emily E. Brown

20 papers receiving 872 citations

Peers

Countries citing papers authored by Emily E. Brown

Since Specialization

Citations

This map shows the geographic impact of Emily E. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily E. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily E. Brown more than expected).

Fields of papers citing papers by Emily E. Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily E. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily E. Brown. The network helps show where Emily E. Brown may publish in the future.

Co-authors

The 25 scholars most cited alongside Emily E. Brown, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Emily E. Brown Line = papers co-authored together Emily E. Brown links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Mitochondrial oxidative stress in the retinal pigment epithelium (RPE) led to metabolic dysfunction in both the RPE and retinal photoreceptors Redox Biology ·Emily E. Brown, Alexander J. DeWeerd, Cristhian J. Ildefonso, Alfred S. Lewin, John D. Ash	2019	186
2	The specificity of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase as inferred from a database of in vivo substrates and from the in vitro glycosylation of proteins and peptides Journal of Biological Chemistry ·Åke P. Elhammer, Roger A. Poorman, Emily E. Brown, Linda Maggiora, John G. Hoogerheide, Ferenc J. Kézdy	1993	148
3	Chemical Genomics Identifies Small-Molecule MCL1 Repressors and BCL-xL as a Predictor of MCL1 Dependency Cancer Cell ·Guo Wei, Adam A. Margolin, Leila Haery, Emily E. Brown, Lisa Cucolo, Bina Julian, Shyemaa Shehata, Andrew L. Kung, Rameen Beroukhim, Todd R. Golub	2012	140
4	The Common Antidiabetic Drug Metformin Reduces Odds of Developing Age-Related Macular Degeneration Investigative Ophthalmology & Visual Science ·Emily E. Brown, Jacob D. Ball, Zhaoyi Chen, Gibran S. Khurshid, Mattia Prosperi, John D. Ash	2019	79
5	Mitochondria: Potential Targets for Protection in Age-Related Macular Degeneration Advances in experimental medicine and biology ·Emily E. Brown, Alfred S. Lewin, John D. Ash	2018	56
6	Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cells Cancer Letters ·Dalit Landesman‐Milo, Meir Goldsmith, Shani Leviatan Ben‐Arye, Bruria Witenberg, Emily E. Brown, Sigalit Leibovitch, Shalhevet Azriel, Sarit Tabak, Vered Morad, Dan Peer	2012	55
7	Designer Lipid-Like Peptides: A Class of Detergents for Studying Functional Olfactory Receptors Using Commercial Cell-Free Systems PLoS ONE ·Karolina Corin, Philipp Baaske, Deepali Ravel, Junyao Song, Emily E. Brown, Xiaoqiang Wang, Christoph J. Wienken, Moran Jerabek‐Willemsen, Stefan Duhr, Yuan Luo, Dieter Braun, Shuguang Zhang	2011	41
8	A Robust and Rapid Method of Producing Soluble, Stable, and Functional G-Protein Coupled Receptors PLoS ONE ·Karolina Corin, Philipp Baaske, Deepali Ravel, Junyao Song, Emily E. Brown, Xiaoqiang Wang, Sandra Geissler, Christoph J. Wienken, Moran Jerabek‐Willemsen, Stefan Duhr, Dieter Braun, Shuguang Zhang	2011	38
9	A cell penetrating peptide from SOCS-1 prevents ocular damage in experimental autoimmune uveitis Experimental Eye Research ·Chulbul M. Ahmed, Michael T. Massengill, Emily E. Brown, Cristhian J. Ildefonso, Howard M. Johnson, Alfred S. Lewin	2018	30
10	Targeting the Nrf2 Signaling Pathway in the Retina With a Gene-Delivered Secretable and Cell-Penetrating Peptide Investigative Ophthalmology & Visual Science ·Cristhian J. Ildefonso, Henrique Jaime, Emily E. Brown, Ryo Iwata, Chulbul M. Ahmed, Michael T. Massengill, Manas R. Biswal, Sanford L. Boye, William W. Hauswirth, John D. Ash, Qiuhong Li, Alfred S. Lewin	2016	30
11	Up-Regulation Thioredoxin Inhibits Advanced Glycation End Products-Induced Neurodegeneration Cellular Physiology and Biochemistry ·Xiang Ren, Na Wang, Hui Qi, Yuanyuan Qiu, Chenghong Zhang, Emily E. Brown, Hui Kong, Li Kong	2018	27
12	Gene Therapy Preserves Retinal Structure and Function in a Mouse Model of NMNAT1-Associated Retinal Degeneration Molecular Therapy — Methods & Clinical Development ·Scott H. Greenwald, Emily E. Brown, Michael J. Scandura, Erin Hennessey, Raymond Farmer, Basil S. Pawlyk, Ru Xiao, Luk H. Vandenberghe, Eric A. Pierce	2020	13
13	Mutant Nmnat1 leads to a retina-specific decrease of NAD+ accompanied by increased poly(ADP-ribose) in a mouse model of NMNAT1-associated retinal degeneration Human Molecular Genetics ·Scott H. Greenwald, Emily E. Brown, Michael J. Scandura, Erin Hennessey, Raymond Farmer, Jianhai Du, Yekai Wang, Eric A. Pierce	2021	13
14	Prevention of acute graft-versus-host disease by treatment with a novel immunosuppressant. Cholera toxin B subunit. The Journal of Immunology ·B Yankelevich, Emily E. Brown, A Mazumder	1995	9
15	Reduced nuclear NAD+ drives DNA damage and subsequent immune activation in the retina Human Molecular Genetics ·Emily E. Brown, Michael J. Scandura, Sudeep Mehrotra, Yekai Wang, Jianhai Du, Eric A. Pierce	2021	8
16	Retinal homeostasis and metformin-induced protection are not affected by retina-specific Pparδ knockout Redox Biology ·Lei Xu, Emily E. Brown, Clayton P. Santiago, Casey Keuthan, Екатерина С. Лобанова, John D. Ash	2020	5
17	AMPK May Play an Important Role in the Retinal Metabolic Ecosystem Advances in experimental medicine and biology ·Emily E. Brown, Alfred S. Lewin, John D. Ash	2019	5
18	Expression of NMNAT1 in the photoreceptors is sufficient to prevent NMNAT1-associated retinal degeneration Molecular Therapy — Methods & Clinical Development ·Emily E. Brown, Michael J. Scandura, Eric A. Pierce	2023	2
19	Deletion of Mitochondrial Antioxidant Enzyme Sod2 Induces Light-Dependent Retinal Degeneration with Aging Investigative Ophthalmology & Visual Science ·Emily E. Brown, John D. Ash, Alfred S. Lewin	2017	1
20	Role of Nuclear NAD+ in Retinal Homeostasis Advances in experimental medicine and biology ·Emily E. Brown, Michael J. Scandura, Eric A. Pierce	2023	1

About Emily E. Brown

Emily E. Brown is a scholar working on Ophthalmology, Physiology, Geriatrics and Gerontology, Physical and Theoretical Chemistry and Molecular Biology, having authored 20 papers that have together received 887 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (6 papers), Retinal Development and Disorders (6 papers), Retinoids in leukemia and cellular processes (3 papers), Cytomegalovirus and herpesvirus research (3 papers), Calcium signaling and nucleotide metabolism (3 papers), Lipid Membrane Structure and Behavior (2 papers), PARP inhibition in cancer therapy (2 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Ophthalmology (283 citations), Molecular Biology (639 citations), Neurology (54 citations), Radiology, Nuclear Medicine and Imaging (132 citations) and Immunology (115 citations). Emily E. Brown has collaborated with scholars based in United States, China and Germany. Frequent co-authors include John D. Ash, Alfred S. Lewin, Cristhian J. Ildefonso, Linda Maggiora, John G. Hoogerheide, Åke P. Elhammer, Ferenc J. Kézdy, Roger A. Poorman, Guo Wei and Andrew L. Kung. Their work appears in journals such as Advances in experimental medicine and biology, Investigative Ophthalmology & Visual Science, Human Molecular Genetics, Redox Biology and Molecular Therapy — Methods & Clinical Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact